Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.
A large-scale healthcare acquisition, which features a portfolio of veterinary generics, has been terminated.
Alivira Animal Health has gained a considerable manufacturing footprint in Europe by purchasing a subsidiary from a fellow Indian veterinary medicines firm.
US generic drug manufacturer Perrigo has recorded a decline in its annual animal health sales for the third consecutive year.
Slovenian pharmaceutical company Krka has seen its animal health sales remain stable over 2017 with 1% year-on-year growth.
Pharmgate and Norbrook Laboratories have both received approval for generic products from the US FDA.
The UK's leading animal health company Dechra Pharmaceuticals will add to its generics expertise with the purchase of two prominent Dutch veterinary products companies.
Bulgarian animal health generics specialist Huvepharma will be able to combine its recent expansion efforts in the US with growth nearer to home following a substantial loan.
Dutch company Le Vet Pharma has continued to add to its European portfolio of generic anesthetics with its 12th and 13th product approvals of 2017.
The European Medicines Agency (EMA) has made a significant move in paving the way for more innovative animal health products by introducing its first guidance on monoclonal antibodies.
Dutch firm Le Vet Pharma has received European approval for two generic companion animal products.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved products from Virbac, IDEXX Laboratories and three local companies.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.